» Articles » PMID: 37004193

RE: Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents with Cancer

Overview
Specialty Oncology
Date 2023 Apr 2
PMID 37004193
Authors
Affiliations
Soon will be listed here.
Citing Articles

Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.

Groves A, Ward A, Li Y, Lazo de la Vega L, Nag A, Forrest S Pediatr Blood Cancer. 2023; 70(11):e30643.

PMID: 37596911 PMC: 10883645. DOI: 10.1002/pbc.30643.


Reply to Li and Colleagues.

Kratz C, Smirnov D, Autry R, Jager N, Waszak S, Grosshennig A J Natl Cancer Inst. 2023; 115(6):760-761.

PMID: 37004196 PMC: 10248829. DOI: 10.1093/jnci/djad057.

References
1.
Li S, MacInnis R, Lee A, Nguyen-Dumont T, Dorling L, Carvalho S . Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. Am J Hum Genet. 2022; 109(10):1777-1788. PMC: 9606477. DOI: 10.1016/j.ajhg.2022.09.006. View

2.
Kratz C, Smirnov D, Autry R, Jager N, Waszak S, Grosshennig A . Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer. J Natl Cancer Inst. 2022; 114(11):1523-1532. DOI: 10.1093/jnci/djac151. View

3.
Southey M, Dowty J, Riaz M, Steen J, Renault A, Tucker K . Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing. NPJ Breast Cancer. 2021; 7(1):153. PMC: 8660783. DOI: 10.1038/s41523-021-00360-3. View

4.
Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C . Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med. 2021; 384(5):428-439. PMC: 7611105. DOI: 10.1056/NEJMoa1913948. View

5.
Evans D, Woodward E . RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer. J Natl Cancer Inst. 2022; 115(2):224-225. PMC: 9905954. DOI: 10.1093/jnci/djac223. View